Rab 31 inhibitors constitute a class of chemical compounds that have garnered attention in the fields of molecular biology and pharmacology due to their role in modulating specific cellular processes. Rab proteins are a family of small GTPases that are instrumental in regulating intracellular vesicular trafficking and membrane transport. Rab 31, a member of this family, plays a vital role in the coordination of vesicle trafficking within cells, helping to ensure that cargo molecules are delivered to their intended destinations. Rab 31 inhibitors are designed to interact with the active site or binding domain of the Rab 31 protein, effectively inhibiting its GTPase activity and interfering with its normal function in regulating vesicular transport.
Structurally, Rab 31 inhibitors are tailored to selectively target the active site of Rab 31, ensuring high specificity for this particular GTPase. By inhibiting Rab 31, these compounds may disrupt the dynamics of vesicle trafficking, affecting processes such as endocytosis, exocytosis, and intracellular membrane fusion. The study of Rab 31 inhibitors is of significant interest to researchers as it provides insights into the regulatory mechanisms governing essential cellular functions, particularly in the context of intracellular transport and membrane dynamics. This knowledge contributes to our understanding of basic cell biology and may have implications in various research areas, including cell trafficking, organelle biogenesis, and membrane-related diseases. However, further research is needed to fully explore the extent of their applications and their impact on cellular physiology in the context of vesicular transport.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Mycophenolate mofetil | 128794-94-5 | sc-200971 sc-200971A | 20 mg 100 mg | $37.00 $109.00 | 1 | |
Inhibits inosine monophosphate dehydrogenase, potentially affecting cellular proliferation and indirectly Rab 31 expression. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Inhibits protein synthesis, potentially reducing Rab 31 expression at the translational level. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $63.00 $110.00 $214.00 | 1 | |
A nucleoside analog, could interfere with RNA metabolism and potentially affect Rab 31 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR pathway, which could influence Rab 31 expression through effects on cell growth and proliferation. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Inhibits V-ATPase, affecting endosomal acidification and potentially Rab 31 expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor, potentially affecting signaling pathways that regulate Rab 31 expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Affects endosome-lysosome fusion, potentially influencing Rab 31 expression indirectly. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Similar to Chloroquine, could affect cellular trafficking and indirectly Rab 31 expression. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Inhibits dynamin, potentially affecting endocytic pathways and indirectly Rab 31 expression. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
As a tyrosine kinase inhibitor, could affect signaling pathways that regulate Rab 31 expression. | ||||||